Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Landgren

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
Contraception|April 1, 1980
A comparison of the pharmacokinetic properties of three estradiol estersM A Oriowo, B M Landgren, B Stenström, et al.
Hormone Research|January 1, 1991
Plasma estriol levels after intramuscular injection of estriol and two of its estersR Heithecker, A R Aedo, B M Landgren, et al.
Contraception|February 1, 1994
Pharmacokinetic and pharmacodynamic effects of vaginal rings releasing levonorgestrel at a rate of 27 micrograms/24 hours: a pilot studyB M Landgren, A R Aedo, E Johannisson, et al.
Lakartidningen|February 24, 2001
[Climacteric--medicalization, minimalization or normalization?]B Hovelius, H Ekström, J Esseveld, et al.
Thrombosis and Haemostasis|January 23, 1992
On the intraindividual and gender variability of haemostatic componentsM Blombäck, P Eneroth, B M Landgren, et al.
Acta Endocrinologica|July 1, 1978
Effect of two progestins on human endometrial enzymes and trace elementsJ Jelínek, M Jelínková, K Hagenfeldt, et al.
The American Journal of Cardiology|July 25, 1998
Effect of conjugated estrogen on peripheral flow-mediated vasodilation in postmenopausal womenF Al-Khalili, M Eriksson, B M Landgren, et al.
Contraception|July 1, 1994
Studies on a vaginal ring releasing levonorgestrel at an initial rate of 27 micrograms/24 h when used alone or in combination with transdermal systems releasing estradiolB M Landgren, A R Aedo, E Johannisson, et al.
Maturitas|June 1, 1989
Effect of orally administered oestrogens on gonadotrophin levels in post-menopausal womenA R Aedo, M Le Donne, B M Landgren, et al.
Contraception|December 1, 1996
The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17 beta-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg desogestrel only for 7 daysG Csemiczky, T Dieben, H J Coeling Bennink, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Contraception|April 1, 1980
A comparison of the pharmacokinetic properties of three estradiol estersM A Oriowo, B M Landgren, B Stenström, et al.
Hormone Research|January 1, 1991
Plasma estriol levels after intramuscular injection of estriol and two of its estersR Heithecker, A R Aedo, B M Landgren, et al.
Contraception|February 1, 1994
Pharmacokinetic and pharmacodynamic effects of vaginal rings releasing levonorgestrel at a rate of 27 micrograms/24 hours: a pilot studyB M Landgren, A R Aedo, E Johannisson, et al.
Lakartidningen|February 24, 2001
[Climacteric--medicalization, minimalization or normalization?]B Hovelius, H Ekström, J Esseveld, et al.
Thrombosis and Haemostasis|January 23, 1992
On the intraindividual and gender variability of haemostatic componentsM Blombäck, P Eneroth, B M Landgren, et al.
Acta Endocrinologica|July 1, 1978
Effect of two progestins on human endometrial enzymes and trace elementsJ Jelínek, M Jelínková, K Hagenfeldt, et al.
The American Journal of Cardiology|July 25, 1998
Effect of conjugated estrogen on peripheral flow-mediated vasodilation in postmenopausal womenF Al-Khalili, M Eriksson, B M Landgren, et al.
Contraception|July 1, 1994
Studies on a vaginal ring releasing levonorgestrel at an initial rate of 27 micrograms/24 h when used alone or in combination with transdermal systems releasing estradiolB M Landgren, A R Aedo, E Johannisson, et al.
Maturitas|June 1, 1989
Effect of orally administered oestrogens on gonadotrophin levels in post-menopausal womenA R Aedo, M Le Donne, B M Landgren, et al.
Contraception|December 1, 1996
The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17 beta-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg desogestrel only for 7 daysG Csemiczky, T Dieben, H J Coeling Bennink, et al.
Pageof 13